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Abstract
Background: Dizziness and comorbid anxiety may cause severe disability of patients with vestibulopathy, but can
be addressed effectively with rehabilitation. For an individually adapted treatment, a structured assessment is
needed. The Vertigo Symptom Scale (VSS) with two subscales assessing vertigo symptoms (VSS-VER) and associated
symptoms (VSS-AA) might be used for this purpose. As there was no validated VSS available in German, the aim of
the study was the translation and cross-cultural adaptation in German (VSS-G) and the investigation of its reliability,
internal and external validity.
Methods: The VSS was translated into German according to recognized guidelines. Psychometric properties were
tested on 52 healthy controls and 202 participants with vestibulopathy. Internal validity and reliability were
investigated with factor analysis, Cronbach’s α and ICC estimations. Discriminant validity was analysed with the
Mann–Whitney-U-Test between patients and controls and the ROC-Curve. Convergent validity was estimated with
the correlation with the Hospital Anxiety Subscale (HADS-A), Dizziness Handicap Inventory (DHI) and frequency of
dizziness.
Results: Internal validity: factor analysis confirmed the structure of two subscales. Reliability: VSS-G: α= 0.904 and
ICC (CI) =0.926 (0.826, 0.965). Discriminant validity: VSS-VER differentiate patients and controls ROC (CI) =0.99 (0.98,
1.00). Convergent validity: VSS-G correlates with DHI (r = 0.554) and frequency (T = 0.317). HADS-A correlates with
VSS-AA (r = 0.452) but not with VSS-VER (r = 0.186).
Conclusions: The VSS-G showed satisfactory psychometric properties to assess the severity of vertigo or vertigo-
related symptoms. The VSS-VER can differentiate between healthy subjects and patients with vestibular disorders.
The VSS-AA showed some screening properties with high sensitivity for patients with abnormal anxiety.
Background
With a lifetime prevalence of 29.3 percent in the general
German adult population, moderate to severe vertigo or
dizziness is a frequent and often recurrent symptom [1].
Furthermore, as 80 percent of the patients reported se-
vere limitations in daily activities [1], a considerable cur-
tailing in health-related quality of life may be expected.
Moderate to severe vertigo or dizziness can interrelate
with psychiatric disorders, especially anxiety [2-6], which
may increase disability [4].
The severity of symptoms and the perceived limitations
in activities of daily life can be addressed effectively by in-
dividually tailored vestibular rehabilitation based on ves-
tibular habituation to movement [7-10], optionally
combined with cognitive behavioural therapy [11-13]. A
requirement for an individually tailored treatment is an
assessment, which has to be carried out as thoroughly as
possible. In order to focus on the symptoms associated
with dizziness, the Vertigo Symptom Scale (VSS) was con-
sidered to be a key instrument. The VSS consists of two
subscales: 1) the Vertigo scale (VSS-VER) which assesses
symptoms mainly associated with disorders of the vestibu-
lar system and 2) the Anxiety and Autonomic symptom
scale (VSS-AA) for the assessment of a group of generic
symptoms which may be associated with autonomic
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arousal or somatic expressions of anxiety [14]. The ori-
ginal VSS as well as a Spanish and a Swedish version
showed acceptable psychometric properties [5,15]. How-
ever, at the beginning of the study (Spring 2007) there was
no validated VSS available in German. The author of the
original VSS, L. Yardley [14] was contacted and she con-
firmed that she had no knowledge of a currently on-going
validation. Hence, she approved the German translation
and cross-culturally adaptation of the VSS and its valid-
ation. Thereby we intended to apply an approved method-
ology guideline for the translation process [16,17] and to
take in consideration existing cultural and language differ-
ences between the German-speaking populations in
Europe (e.g., Austria, Germany, Belgium, Switzerland,
Italy) [18]. A German version of the VSS from Tschan
et al. [19] that in the meantime was published did not spe-
cifically comply with guidelines (e.g. use informed and un-
informed translators and back-translators) and neither
considered the possibility of cross-cultural differences,
which might have biased their results. For this reason the
primary aim of the study was the translation and the
cross-cultural adaptation of the VSS into German for the
German-speaking population of Switzerland and to inves-
tigate its internal validity and reliability for patients with
vestibulopathy. The secondary aim of the study was the
investigation of the discriminant and convergent validity
as parts of external validity determination.
Methods
Translation and cross cultural adaptation of the VSS
The VSS is a self-completed, 34-item questionnaire (19
items for VSS-VER and 15 for VSS-AA). The frequency
of the symptoms is rated on a Likert-scale: 0 points:
“never”, 1 point: “a few times (1–3 times a year)”, 2
points: “several times (4–12 times a year)”, 3 points:
“quite often (on average, more than once a month)” and
4 points: “very often (on average more than once a
week)”. The total score aims to figure out the latent di-
mension of severity of dizziness and ranges from 0
points (no symptoms) to 136 points (severe vertigo).
The translation and cross-cultural adaptation into
German was performed in six steps, according to the inter-
national guidelines for self-reported measures published by
the American Association of Orthopaedic Surgeons Out-
come Committee [16] and additional information about
requirements for translators fromWild et al. [17]. First step:
two independent German VSS-translations were requested
in order to reflect possible ambiguous wording. Two native
German-speaking translators with excellent English lan-
guage skills translated independently the VSS into German.
Moreover, as recommended by Wild [17], one translator
was aware of the measured concept of the VSS (health pro-
fessional), the other not. Second step: meeting of both of
the translators and an observer to keep record of the
merger of both translations and in order to resolve discrep-
ancies. Third step: back translation of the previously
obtained German version into English by two independent
native English speaking translators with German language
skills, both translators were withheld of the original version
of the VSS, again one person was aware of the concept the
other not. This step was necessary in order to bring out un-
clear wording or cultural peculiarities in symptom descrip-
tion and to help to assure a consistent translation of the
content of each item. Fourth step: an expert committee
consisting of the four translators, the methodologist and
two health and language professionals produced the pre-
final version of the VSS. Prior to this meeting; Lucy Yardley
(author of the original VSS) compared the original VSS
with both back translations. Her comments were also con-
sidered in the discussion. Fifth step: the pre-final VSS-G
was pilot tested according to the recommendations of Wild
[17] in a group of fourteen patients who fulfilled the inclu-
sion/exclusion criteria below. Sixth step: The transcription
of the patient interviews and the documents of the preced-
ing steps were analysed in the final stage and the final ver-
sion of the VSS-G was written. Since cross-cultural
differences exist between German-speaking countries [18]
and both Swiss and German patients frequent our hospital,
special consideration was given to specifically include both
German and Swiss cultural background translators and
physiotherapists in our research team.
Participants
The study participants were suffering from vertigo, dizzi-
ness, or unsteadiness associated with a diagnosed ves-
tibular disorder for at least one month. They had to be
between 18 and 75 years old, capable of walking and in-
dependently managing approximately 50% of their daily
tasks and have good German language skills. The exclu-
sion criteria comprised dizziness or unsteadiness exclu-
sively due to cardiopulmonary diseases, musculoskeletal
problems or neurologic disorders like severe paresis,
spasticity, cerebellar ataxia, extrapyramidal diseases, or
sensory loss. Furthermore, patients with diagnosed de-
mentia, psychiatric disorders or blindness were excluded.
Recruitment took place between July 2007 and July 2009
through the Interdisciplinary Centre for Vertigo & Bal-
ance Disorders, Departments of ENT, Neurology and
Psychiatry at the University Hospital Zurich. All patients
who were referred to the department were asked to par-
ticipate in this study. Those who met the criteria and
submitted their signed written informed consent were
included in the study. Healthy participants were mainly
family members or friends of the authors and their col-
leagues and were also included after submitting their
signed written informed consent. The approval of the
ethics committee of the Canton of Zurich was obtained
in accordance with the Declaration of Helsinki.
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Measures
The Hospital Anxiety and Depression Scale (HADS) is a
14-item questionnaire measuring psychological distress. It
is divided into two subscales assessing non-somatic symp-
toms of anxiety and depression [20]. Although the whole
questionnaire was submitted to the participants, only the
results of the anxiety subscale are reported here. The items
are rated from 0 to 3 points and the score ranges from 0
(no sign of anxiety) to 21 (maximum level of anxiety). The
validity of the HADS has been demonstrated by a large
number of patient groups. The psychometric properties of
the German version are good and the recommended cut-
off score for screening abnormal anxiety is eleven [21].
The Dizziness Handicap Inventory (DHI) [22] is a
25-item questionnaire designed to evaluate the precipi-
tating physical factors associated with dizziness and
unsteadiness as well as the functional and emotional
consequences of vestibular disease[22]. The items were
rated with “yes” (4 points), “sometimes” (2 points) and
“no” (0 points). The total score ranges from zero (no
disability) to 100 (severe disability). The original ver-
sion demonstrated good face validity, internal
consistency and test-retest reliability in a population
with different aetiologies of dizziness and unsteadiness
[22]. A valid German version is available [23].
xThree items of the University of California Los
Angeles-Dizziness Questionnaire UCLA-DQ [24] were
used to rate the overall perceived frequency of dizziness
(UCLA-DQ1), its intensity (UCLA-DQ2) and the impact
of dizziness on daily activities (UCLA-DQ3). The pro-
blems were rated on a scale ranging from 1 (lowest level
of the severity of the problem) to 5 (highest level). Fur-
thermore the patients had to rate their level of disability
induced by dizziness as no disability (0 points), mild (1),
moderate (2) or severe (3 points).
The postal data collection procedure for the reliability
and validity investigation are summarized in Figure 1.
The test-retest reliability analysis was carried out on 40
complete pairs of questionnaires [25]. The data collec-
tion procedure was controlled on a daily basis. The qual-
ity was assured by contacting the patients by phone in
order to clear up ambiguous responses, to fill gaps in
the questionnaires or to remind them to return the
questionnaires. All the analysis was performed on IBM
PASW Statistics (formerly SPSS Statistics) version 18
software.
Internal validity determination
Factor analysis
According to the preceding studies [14,19], a principal
component analysis (PCA) for two factors with Varimax
rotation was performed, in order to compare the loadings
of the items on both factors representing the structure of
the subscales (VSS-VER and VSS-AA). Prior to the
statistical analysis, ceiling or floor effects in the VSS-G or
the subscales were checked in the study population.
Reliability determination
Cronbach's α coefficient was calculated to investigate the
internal consistency of the VSS-G and both subscales. For
psychometric scales Cronbach’s α> 0.8 is generally recom-
mended [26]. The Cronbach's α coefficient was also esti-
mated with each item excluded, where the difference
between α-total and α-with-the-item-deleted should not be
greater than 0.1 [27]. The corrected item-total correlations
(CI-TC) were calculated to investigate the strength of rela-
tionship between a single item and the other items in each
of the scales. CI-TC should range between 0.20 and 0.40
[28], with the minimal recommended value of 0.2 [26].
The intra-tester reliability was calculated with the two-way
random model with single measurement intraclass correl-
ation coefficient (ICC2,1 absolute agreement type) [29,30].
External validity determination
Discriminant validity was analysed by comparing the me-
dian scores of VSS-G, VSS-VER and VSS-AA between a
group of 52 healthy subjects and the three diagnostic sub-
groups: “1=peripheral vestibular disorder, 2= central
vestibular disorder and 3=multifactorial/multisensory dis-
orders”. Significant differences between the groups were
investigated with the Mann–Whitney-U-Test for independ-
ent groups. If any significant difference between the groups
was found the ROC curve and the Youden Index [31] were
carried out. The Mann–Whitney-U-Test was further used
to investigate the ability of the VSS-AA median score to dif-
ferentiate abnormal anxiety as defined by the HADS-A
(score≥11).
Convergent validity of the VSS-G and its subscales was
analysed using the Spearman’s correlations to investigate
the association of VSS-G, VSS-VER and VSS-AA with
HADS-A and DHI. Kendall’s Tau rank correlation was
performed to analyse the associations of the VSS with
the estimated level of disability and the 3 items of the
UCLA-DQ: 1) frequency, 2) intensity and 3) impact of
dizziness on daily activities.
Results
After the translation and pilot testing process of a pref-
inal version, the VSS-G was tested with 202 participants
with vertigo or dizziness and 52 healthy subjects (Table 1:
characteristics of participants).
Translation and pilot testing of the prefinal translation of
the VSS-G
Throughout the translation and cross cultural adaptation
process the translators encountered some difficulties to
adapt definitions like: unsteadiness, actually fall, light-
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headed, swimmy, giddy or walk properly for the items of
the VSS-VER. There were also some discussion needed
to adapt descriptions of symptoms of the VSS-AA like:
about to black out, tingling, prickling, spots before the
eyes, heart pounding, soreness in muscles, stomach
churning, hot or cold spells (not to confound with symp-
toms of menopause). However the expert committee in
the fourth step of the process reached consensus for each
item and the patients (in the pilot testing) were able to
recognise and associated the described symptoms with
their vestibular problems. Compared to the German VSS
version that was published during our data gathering
process [19], we found differences in the way sentences
were constructed. This could be due to cross-cultural dif-
ferences between the German-speaking populations in
Germany and Switzerland [18]. However, the wording
used to describe the symptoms was essentially the same.
For the pilot testing (cognitive debriefing) of the pre-
final version, 14 patients (8 male) with vestibular disorders
(8 peripheral (57%), 5 central vestibular disorder (37%)
and 1 multifactorial (7%) causes of dizziness could be
included. The mean age (SD) was 60.5 (14.13) years, the
mean scores of the DHI (SD)= 46 (20.0), the VSS= 49 (25)
and the subscales VSS-VER=24 (14), VSS-AA=25 (13).
The participants estimated the matching of the contents
of the VSS items with their symptoms at 92.2 percent (SD
6.9). One outlier (more than 3 standard deviations differ-
ences to the mean), who could not cite any additional
problem or symptom the VSS was not accounting for, was
excluded from the calculation. Fatigue and weariness were
the most cited problems (3 from 14) which are not
included in the VSS. However, to the best of our know-
ledge, even if both symptoms could appear with vestibular
disorders, there is no association of fatigue as a symptom
of dizziness described in literature. Therefore there was
no item added to the VSS-G. The other cited symptoms
were diarrhoea, inflammation of the pharynx (sensation of
burning while swallowing), polyuria and incontinence,
tickling and itching in the ears, hunger and panic. Some
patients missed items with vertigo-causing activities
(e.g. walking, head movements) or emotions like feeling
helpless or alone, fear of becoming dependent or losing
work. These propositions underpin the necessity to assess
limitations in activity, participation and emotional distress
but are beyond the scope of the VSS. Based on these
results, the VSS-G can be considered to be complete.
Although most patients declared to easily understand
the content of the VSS-G, the interviewers noticed
Inclusion: 
52 healthy persons 
Inclusion: 
202 persons with vertigo, dizziness or 
imbalance 
Baseline set of questionnaires 
adapted for healthy persons: 
VSS-G/ DHI-G/ HADS-G 
Baseline set of questionnaires:
VSS1-G/ DHI-G/ HADS-G/ UCLA-DQ1/
UCLA-DQ2/UCLADQ3 socio-demographic data  
Discriminant Validity: 
• Pairwise U-Test between 
diagnostic groups and 
healthy participants 
• ROC-curve for VSS-VER 
After 1 week, a sample of persons 
assumed to be in stable health 
condition with respect of dizziness 
(n=58) received a second 
questionnaire (VSS2-G) 
Report of 
stable health 
condition 
Exclusion of reliability 
analysis 
no 
n= 18 
yes 
n= 40 Test-Retest Reliability 
• ICC 2,1
Internal validity: 
• PCA with Varimax Rotation (2 
factors) 
Internal Consistency: 
• Cronbach's α / α if item deleted 
• CI-TC 
Construct Validity:  
• Spearman’s Correlation coefficient 
• Kendall’s Tau correlation coefficient 
Figure 1 Flow-chart of data collection and analysis procedure.
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Table 1 Characteristics of participants
Participants with
vestibular disorder (n=202)
Subgroup for
reliability testing (n=40)
Healthy participants (n=52)
Age in years: mean (SD) 50.0 (13.47) 50.7 (13.63) 46.7 (13.12)
Gender: n women/men (% women): 124/78 (61.4) 23/17 (57.5) 28/24 (53.8)
Independence or need of support for ADL/household: n (%)
independent 162 (80.2) 33 (82.5) 52 (100.0)
need of occasional support 27 (13.4) 6 (15.0) 0
need of regular weekly or daily support 13 (6.4) 1 (2.5) 0
Duration of dizziness: n (%)
dizziness since≥ 1 month, less than 6 mo 58 (28.7) 8 (20.0)
dizziness since≥ 6 mo up to 12 mo 27 (13.4) 7 (17.5)
dizziness since> 12 mo 117 (57.9) 25 (62.5)
Diagnosis: n (%)
Unilateral peripheral vestibular disorder: 73 (36.14) 10 (25.00)
unilat BPPV 26 (12.9) 3 (7.5)
unilat. Morbus Meniere 27 (13.4) 4 (10.0)
unilat. neuritis vestibularis 4 (2.0) 2 (5.0)
others 16 (7.9) 1 (2.5)
Bilateral peripheral vestibular disorder: 17 (8.4) 4 (10.0)
bilat. BPPV 2 (1.0) 0
bilat. M. Meniere 1 (.5) 0
bilat. neuritis vestibularis 4 (2.0) 3 (7.5)
others 10 (5.0) 1 (2.5)
Central vestibular disorder: 73 (36.1) 18 (45.0)
incomplete central compensation 7 (3.5) 2 (5.0)
psycho-physical vertigo 17 (8.4) 2 (5.0)
others (e.g. vest. Migraine) 49 (24.3) 14 (35.0)
Multifactorial/multisensory vestibular disorder: 39 (19.3) 8 (20.0)
Self percieved level of disability: n (%)
little 56 (27.7) 7 (17.5)
moderate 100 (49.5) 23 (57.5)
severe 46 (22.8) 10 (25.0)
UCLA 1: frequency of dizziness: n (%)
rarely 23 (11.4) 4 (10.0)
sometimes 91 (45.0) 19 (47.5)
approximately half of the time 39 (19.3) 10 (25.0)
usually 34 (16.8) 4 (10.0)
always 15 (7.4) 3 (7.5)
UCLA 2: Intensity of dizziness: n (%)
very mild 10 (5.0) 2 (5.0)
mild 23 (11.4) 4 (10.0)
moderate 78 (38.6) 17 (42.5)
moderately severe 73 (36.1) 13 (32.5)
severe 18 (8.9) 4 (10.0)
UCLA 3: dizziness induced limitations in activities or participation: n (%)
Gloor-Juzi et al. BMC Ear, Nose and Throat Disorders 2012, 12:7 Page 5 of 13
http://www.biomedcentral.com/1472-6815/12/7
among seven persons (50% of participants) difficulties to
understand how to deal with the two-tiered questions 1,
7 and 18. These items were used to determine the fre-
quency range of a vertigo symptom with different duration.
The main problem seemed to be the two time-related con-
cepts of symptom duration and frequency. These symptoms
might appear or increase with activities (e.g. walking, head
movements) and will last through the whole activity, which
possibly is an additional confusing time-related aspect. A
similar problem was also described by Holmberg for a
Swedish version of the VSS [32], in order to counteract this
problem we used a clear structure in the layout of these
items , even so health professionals may take into account,
that patients will need assistance for rating these items.
Upon suggestion of some patients, the definitions of the
scale-ranking were reported on top margin of each page of
the questionnaire (Additional file 1).
Internal validity determination
Principal component analysis
Table 2 contains the results of the two factors extraction
with a PCA and Varimax rotation and, for the sake of com-
parison, the loadings of previous versions and translations
of the VSS were also displayed [5,14,19]. Compared to the
original VSS, 87% (13/15) of the items could be clearly
associated to the VSS-AA scale. Indeed, sixteen items
loaded> 0.5 on factor one and thirteen of these items were
attributed to Yardley’s original VSS-AA subscale. The three
remaining items were vertigo symptoms lasting for less
than 2 minutes (1a, 7a, 18a). Their allocation to the
VSS-VER subscale will be explained below. Two items
(9, 13) showed a clearly higher loading on factor one than
on factor two; these loadings were between 0.4 and 0.5.
With high face validity, these two items were integrated in
the VSS-AA subscale of VSS-G, so that the VSS-AA sub-
scale was identical to the AA subscale of the original VSS.
The VSS-VER subscale showed not such a clearly item
matching. Only 47% (9/19) of the items were attributed to
the VSS-VER based on their loadings >0.5 on factor two.
Four items with loadings from 0.4 to 0.5 (1b, 1e, 7e, 15)
were added to VSS-VER because this loading was clearly
higher on factor two than factor one. Three items (4, 5, 11)
showed unclear loadings either on factor one or two. They
were allocated to VSS-VER for the following reason. Item
04 “falling over” showed inconsistent loading across the
studies but was attributed to VSS-VER, due to its face val-
idity as a possible symptom in acute vertigo attacks. Simi-
larly, the items 05 “Nausea” and 11 “Vomiting” are two
generic symptoms of the autonomous system and showed,
as expected, somewhat higher loadings on factor one
(VSS-AA). Nevertheless, because of their association to
vestibular disorder, particularly acute vertigo attack, these
symptoms were attributed to VSS-VER. Another issue was
the clear loading on factor one (VSS-AA) of vestibular
symptoms lasting less than 2 minutes (items 1a, 7a, 18a).
This result seems to confirm a trend observed in other
works (Table 2) [5,14,19] and raises the assumption
whether this result represents the interface between vertigo
and anxiety [4] and thus, could be interpreted as an exacer-
bation of autonomic arousal leading to vertigo.
Due to the apparently high stability in face of factor
extraction, particularly for the VSS-AA subscale and the
already documented validity of the structure of the VSS
in general [5,14,19], we suggest to keep Yardley’s original
subscale structure for our VSS-G.
The cumulative percentage of the scores of the VSS-G,
VSS-VER and VSS-AA were analysed. There was no
floor effect of the VSS-G and the subscales to be
assumed in our sample because the respective scores of
the 15 percent threshold [33] lays above the minimal
possible score of zero: VSS-G= 16–17, VSS-VER= 6–7,
VSS-AA=5–6. The same holds true for the ceiling effect
as the scores of the 85 percent threshold [33] lays clearly
under the respective maximal score: VSS-G= 59–60
(maximal score = 136), VSS-VER= 32-33(max = 76), VSS-
AA= 30 (max = 60).
Reliability determination
All the Cronbach’s α-coefficient estimations showed
good internal consistency on scale-level (Table 3). This
was also the case on item-level, as there were no differ-
ences> 0.1 in Cronbach’s α-coefficient estimation in
case the respective item was deleted (Additional file 2)
and the CI-TC showed no value under 0.2. For test-
retest reliability estimations, the mean time between the
first and the second measurement was 5.5 days (SD
1.97 days). As shown in Table 3, all the ICC coefficients
reached the recommended threshold of 0.75 [29].
Table 1 Characteristics of participants (Continued)
no effect at all 15 (7.4) 3 (7.5)
continuing all activities but allowance for dizziness 39 (19.3) 8 (20.0)
continuing most of the activities 79 (39.1) 18 (45.0)
continuing some of the activities 51 (25.2) 9 (22.5)
unable to continue any of the activities 18 (8.9) 2 (5.0)
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Table 2 PCA with Varimax Rotation: table for two factor loadings comparison
Item Factor 1 Factor 2
CH Germany Mexic hosp UK hosp. Prim care (UK) Swiss Germany Mexic hosp UK hosp Prim care (UK)
01. Things spinning/moving (V**):
a. less than 2 min 0.55 0.35 0.46* 0.34 0.24 0.02 0.13 −0.07 0.21 −0.06
b. 2 to 20 min 0.27 0.08 0.12 0.13 0.14 0.47* 0.64 0.53 0.71 0.44*
c. 20 min to 1 h 0.17 0.08 −0.03 −0.02 0.13 0.60 0.65 0.54 0.83 0.74
d. several hours −0.08 −0.01 −0.09 −0.08 −0.08 0.63 0.52 0.59 0.71 0.68
e. more than 12 h −0.02 0.25 −0.02 0.06 −0.03 0.43* 0.06 0.51 0.52 0.36
02. Heart/chest pain (A***) 0.52 0.52 0.67 0.52 0.52 −0.06 0.04 0.09 −0.14 −0.19
03. Hot or cold spells (A) 0.66 0.61 0.67 0.59 0.65 0.16 0.07 0.25 0.16 0.12
04. Falling over (V) 0.40* 0.42* 0.28 0.27 0.40* 0.24 0.20 0.44* 0.36 0.23
05. Nausea, feeling sick (V) 0.47* 0.50 0.58 0.40* 0.56 0.32 0.14 0.35 0.36 0.23
06. Muscle tension/sore (A) 0.63 0.68 0.81 0.67 0.57 0.08 0.14 0.01 0.01 0.18
07. Light-headed/giddy (V):
a. less than 2 min 0.54 0.28 0.50 0.43* 0.28 0.05 0.17 −0.07 0.11 −0.06
b. 2 to 20 min 0.40 0.18 0.30 0.17 0.11 0.60 0.65 0.46* 0.70 0.53
c. 20 min to 1 h 0.21 0.08 0.13 0.18 0.08 0.73 0.77 0.65 0.70 0.74
d. several hours 0.11 0.10 0.08 0.04 0.12 0.70 0.56 0.71 0.73 0.69
e. more than 12 h 0.05 0.24 0.17 0.02 −0.09 0.45* 0.16 0.50 0.46* 0.55
08. Trembling, shivering (A) 0.56 0.63 0.67 0.56 0.53 0.15 0.08 0.27 0.02 0.16
09. Pressure in the ear (A) 0.41* 0.57 0.60 0.27 0.46* 0.06 0.12 0.16 0.24 0.09
10. Heart pounding (A) 0.54 0.59 0.58 0.66 0.64 0.10 −0.12 0.23 0.02 0.09
11. Vomiting (V) 0.22 0.15 0.30 0.01 0.26 0.12 0.22 0.28 0.32 0.38
12. Heavy feeling arms/legs (A) 0.58 0.74 0.72 0.59 0.70 0.24 0.04 0.04 0.04 0.02
13. Visual disturbances (A) 0.42* 0.71 0.72 0.58 0.61 0.11 0.14 0.16 0.10 0.18
14. Headache/pressure (A) 0.57 0.48* 0.71 0.52 0.58 0.11 0.18 0.23 0.06 0.11
15. Unable to stand/walk (V) 0.16 0.40* 0.38 0.27 0.54 0.42* 0.18 0.40* 0.35 0.35
16. Breathing difficulties (A) 0.63 0.69 0.62 0.53 0.72 0.05 −0.07 0.08 0.06 −0.02
17. Loss of concentration (A) 0.56 0.59 0.64 0.61 0.72 0.28 0.05 −0.03 0.05 0.15
18. Feeling unsteady (V):
a. less than 2 min 0.60 0.27 0.54 0.42 0.24 0.22 0.22 0.13 0.13 −0.04
b. 2 to 20 min 0.39 0.12 0.28 0.13 0.10 0.64 0.64 0.62 0.71 0.58
c. 20 min to 1 h 0.28 0.02 0.17 0.06 0.13 0.75 0.76 0.66 0.74 0.77
d. several hours −0.00 −0.06 −0.12 −0.03 0.08 0.70 0.60 0.69 0.77 0.68
e. more than 12 h 0.03 0.25 −0.04 0.00 −0.06 0.51 0.29 0.60 0.61 0.49*
19. Tingling, prickling (A) 0.55 0.60 0.75 0.59 0.63 −0.00 0.05 0.00 −0.02 0.06
20. Pain in the lower back (A) 0.59 0.56 0.71 0.56 0.66 −0.04 −0.07 −0.08 −0.20 −0.09
21. Excessive sweating (A) 0.57 0.60 0.19 0.47 0.60 0.21 0.05 0.19 0.12 0.18
22. Feeling faint, black out (A) 0.51 0.61 0.02 0.45 0.60 0.19 0.12 0.26 0.30 0.06
The table is adapted from Tschan (Germany, Mainz) [19] and completed with the results of present study Switzerland, (CH) Interdisciplinary Centre for Vertigo &
Balance Disorders, University Hospital Zurich. Factor loadings ≥0.5 are highlighted in bold face; * highest factor loading in analysis when ≥0.4 (but ≤0.5). As grey
background is not acceptable, it was necessary to add the (V) or (S) definition for ich item; ** (V)= item attributed to VSS-VER; ***(A)= item attributed to VSS-AA.
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External validity determination
Discriminant validity The Mann–Whitney-U-Test
showed significant differences in the distribution of the
median scores of the VSS-G, the VSS-VER (Figure 2)
and VSS-AA between healthy subjects and persons with
vestibular disorders (Table 3). Therefore, the areas under
the ROC-Curve (CI) were calculated: VSS-G= 0.95
(0.92, 0.97), VSS-VER= 0.99 (0.98, 1.00) and VSS-AA
= 0.84 (0.78, 0.89) (Figure 3). According to the Youden
Index [31] the best relationship of 0.95 sensitivity and
1.00 specificity could be set at VSS-VER Score = 4.5 (or
0.24 item mean). Particularly the VSS-VER (Figure 2)
was able to discriminate between healthy subjects and
persons with vestibular disorders. But there was no skill
to differentiate between the groups of diagnosis. The
distribution of median scores of VSS-AA showed a sig-
nificant difference between people without and those
with abnormal anxiety as defined by the HADS-A (Score≥
11). However, the ROC-Curve showed very low specificity.
Convergent validity
In order to confirm the structure of the subscale regard-
ing the possible interaction with anxiety, a different cor-
relation of VSS-VER and VSS-AA with measurement of
anxiety (HADS-A) was expected. According to the def-
inition of the thresholds of Gill-Body [34], the VSS-AA
correlated fairly with the HADS-A, while there was only
low correlation between the VSS-VER and the HADS-A
(Table 4). Furthermore, the VSS-G showed moderate
correlation with self-perceived disability as measured by
the DHI (Table 4). The Kendall Tau rank correlation
Table 3 Internal validity, reliability, discriminant validity results
VSS-G VSS-VER VSS-AA
Cronbach's α [n = 202] .904 .859 .864
ICC (CI) [n = 40] .926 (.826/.965) .920 (.854/.957) .913 (.737/.963)
Medians Healthy [n =52] vs. peripheral vest disorder [n = 90] U 326.50 43.00 1046.50
Z −8.529* −9.782* −5.486 8*
Medians Healthy [n = 52] vs. central vest. disorder [n = 73] U 153.500 22.000 467.500
Z −8.742* −9.467* −7.171*
Medians Healthy [n = 52] vs. multifactorial disorder [n = 39] U 89.50 62.00 210.00
Z −7.421* −7.797* −6.456*
No anxiety [n=166] vs. abnormal anxiety [n = 36] U 1776.50 2446.00 1427.00
Z −3.811* −1.706 −4.912*
* Significant (2 tailed) at a <0.001 level.
VSS-G = VSS total score, VSS-VER = VSS vertigo subscale, VSS-AA =VSS somatic anxiety subscale. Mann–Whitney-U-test (U) 1) for comparison of median VSS-VER
scores between healthy and diagnostic groups, 2) median VSS-AA scores between patients without and patients with anxiety (HADS-A ≥11).
Figure 2 Medians and interquartile range of VSS-VER subscores of the three diagnostic groups and healthy subjects.
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coefficient (Table 5) showed a significant but only fair
correlation between the VSS-G and the self-rated fre-
quency of dizziness (UCLA-DQ1), this correlation could
partly be displayed by the box plot of the VSS-G median
scores against the UCLA-DQ1 (Figure 4). The VSS-G
total score and both subscores correlated fairly with
self-estimated (mild, moderate, severe) disability. The
impact on daily activities correlated fairly with VSS-G
and VSS-VER; however, it only correlated weakly with
VSS-AA.
Discussion
The VSS was translated and cross-culturally adapted into
German for a wider German speaking population of
Switzerland. The original’s structure of the subscales
could be confirmed and acceptable psychometric
properties were found. The VSS-G may be adopted to
collect the self-perceived symptoms of patients with
vestibular disorders and to integrate the information in
the treatment plan.
Internal validity determination
Reliability determination
The VSS-G translation exhibits high internal consistency
and acceptable test-retest reliability, similar to the original
VSS and its subscales [14]. This indicates the ability of the
translated instrument to reliably screen groups of patients.
The aspect of agreement was not analysed in the study
[35]; however, as the VSS was conceived to screen the fre-
quency of the symptoms rather than to measure change,
this was not deemed a compulsory psychometric character-
istic. However, we admit that measuring change remains an
important topic in vestibular rehabilitation. The short form
of the VSS [36,37], for which acceptable limits of agreement
were found in a Turkish translation [38], seems to be an ap-
propriate instrument for this purpose. The findings of this
study justify a German language translation for the short
form VSS for the purpose of establishing an instrument
capable of measuring change in symptoms.
External validity determination
Discriminant validity
Particularly the VSS-VER subscale was able to discriminate
between healthy subjects and people with dizziness. If the
determined VSS-VER cut-off score would be applied,
eleven participants out of 252 (4.5%) were misclassified as
Figure 3 ROC-Curve for discrimination between dizzy patients and healthy subjects.
Table 4 Spearman’s correlation coefficients
Spearman's Rho n=202 VSS-G VSS-VER VSS-AA HADS-A
VSS-VER .875**
VSS-AA .865** .549**
HADS-A .369** .186** .452**
DHI .554** .496** .464** .448**
**. The correlation is significant on a 0,01 Level (two sided). VSS-G = VSS total
score, VSS-VER = VSS vertigo subscale, VSS-AA=VSS somatic anxiety subscale,
DHI =Dizziness Handicap Inventory total score, HADS-A=Hospital Anxiety and
Depression Scale - Anxiety subscale).
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false negatives. This may indicate that the vestibular symp-
toms of these patients are very low, which may mislead to
scrutinise the effectiveness of a vestibular rehabilitation.
Therefore, particularly for these patients all the aspects of
the health problems like comorbidities and limitations in
activities of daily life and participation should be considered
in the treatment plan. Anyway, further investigations were
necessary to analyse the usefulness of this cut-off score
prior to vestibular rehabilitation. The low discriminant
properties for vestibular disorders of the VSS-AA may
highlight the interface between vestibular dysfunction and
disorders of autonomous system and anxiety. In contrast
the VSS-AA subscale seemed capable to screen for possible
abnormal anxiety, but it seems fair to state that further re-
search is needed on this discriminative property.
Convergent validity
The low association of the VSS-VER with the HADS-A
seems to imply that our finding might confirm Yardley’s
research for a tool to measure the severity of vertigo symp-
toms, which is supposed to be uncontaminated by anxiety
[14]. On the other hand, the VSS-AA’s fair association with
HADS-A and its discriminant property for abnormal anx-
iety, may suggest that the symptoms of VSS-AA might be
associated with an anxiety disorder. This may confer to the
subscale a certain ability to screen for possible anxiety pro-
blems without providing any other conclusive information
about anxiety (e.g. aetiology of comorbidity). This property
may be helpful in rehabilitation management to counsel the
patients and refer them to health professionals experienced
in psychological disorders for further assessment.
The influence of the severity of the symptoms on limita-
tions of daily activities was showed by correlations of the
VSS-G with measurements of dizziness related disability in
daily activities (DHI, UCLA-DQ3) and the self-estimated
disability due to dizziness. These findings are comparable
to the work of Tamber et al.[39], who showed an associ-
ation between the Norwegian VSS short-form and the DHI;
Table 5 Kendall’s Tau rank correlation coefficients of VSS with self-estimated disability and 3 items of UCLA-DQ
Kendall-Tau n= 202 VSS-G VSS-VER VSS-AA frequency intensity disability
VSS-VER .711**
VSS-AA .703** .397**
frequency (UCLA-DQ1) .317** .262** .299**
intensity (UCLA-DQ2) .227** .275** .108* .101
disability .400** .385** .321** .369** .469**
impact on daily activities (UCLA-DQ3) .281** .309** .172** .133* .590** .508**
** correlation is significant on a 0,01 Level (two sided).
* correlation is significant on a 0,05 Level (two sided).
VSS-G = VSS-G total score, VSS-VER = VSS vertigo subscale, VSS-AA=VSS somatic anxiety subscale; UCLA-DQ1= self-estimated frequency of dizziness, UCLA-DQ2
= self-estimated intensity of dizziness, UCLA-DQ3 = self-estimated impact of dizziness on daily activities; disability = self-rated mild, moderate, severe disability.
Figure 4 VSS-G median scores plotted to dizziness frequency (UCLA-DQ1).
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and Yardley who measured disability with the Vertigo
Handicap Questionnaire [5,14].
Further than disability, symptoms may also have some
influence on health-related quality of life (HRQoL). This
is an important issue, as HRQoL measurement figures
out the dimension of the impact of dizziness on the
patient’s participation to social life. 1) In order to meas-
ure the outcome of vestibular rehabilitation Morris et al.
[40,41] developed the Vestibular Rehabilitation Benefit
Questionnaire (VRBQ) with a HRQoL subscale, which
showed a moderate correlation to the VSS. However, this
result should be interpreted cautiously, because there
were VSS items included in this VRBQ subscale. Never-
theless the scale seems useful for measuring changes in
vestibular rehabilitation. 2) Yanik [38] translated and
validated the VSS short-form and the Vertigo, Dizziness
and Imbalance questionnaire (VDI) [42] (containing a
HRQoL subscale) into Turkish, unfortunately there were
no intercorrelations reported. 3) In her work, Tschan[19]
analysed the correlations of the VSS with generic quality
of life measurement (physical and mental health compo-
nents of the SF-36). She found remarkably weaker corre-
lations with HRQoL for the VSS-VER subscale than for
the VSS-AA [19]. However, these results should be inter-
preted cautiously because of a possible lack of relation-
ship between the SF-36 measure and the salient areas of
dizziness. Previously, Prieto et al. [42] recommended the
VDI for more relevant and responsive measurements of
health-related quality of life. However, current in-depth
research on this instrument is lacking, which impedes
the possible discussion about which instrument should
be preferred in future trials. Nevertheless, the findings of
Tschan underpin the influence of emotional or psycho-
logical distress on generally perceived quality of life, which
should also be considered in vestibular rehabilitation.
As both scales measure frequency, it may be surprising
that the plot of the VSS-G median scores to the frequency
of dizziness (UCLA-DQ1, Figure 4) is not more distinct.
The mismatch seems to appear with increasing frequency
(Figure 4) and is probably due to the different structure of
the instruments. As a matter of fact, in the VSS-G several
item scores were added, while the UCLA-DQ1 is a single
overall estimation of the frequency of dizziness. Possibly
there are some confounders influencing frequency: 1) the
described interaction of intensity [43] and/or 2) the non-
negligible mutual influence between the symptoms of both
subgroups (VSS-VER and VSS-AA). Further research is
needed to illustrate the impact of all these possible
interactions.
Further research is also needed to determine the ex-
tent of usefulness of VSS in vestibular rehabilitation
such as the determination of cut-off scores which pro-
duce a relevant predictive evidence for rehabilitation
success on the individual patient level.
Limitations
The present study was not without limitations; the capacity
of the VSS-VER subscale to differentiate between the
designed diagnostic groups could not be reproduced like in
other similar studies. Our group allocation hampered com-
parison of the results unlike those in other studies with
somewhat other classifications. However, it showed to be
appropriate when targeting vestibular rehabilitation. Fur-
thermore, this group allocation yielded quite unequal group
sizes which, in turn, could have biased the results. There-
fore, calculations were carried out with random selections
of cases within the groups in order to balance the group
sizes, and the described differences were maintained. The
fact that in the meantime a German translation of the VSS
was published [19] could be seen as a further limitation.
However, although this translation by a German team was
published during our data collection process, too late to in-
fluence the generation of our version, our work cannot be
outclassed for several reasons. Firstly, our study method-
ology [16,17] took in consideration cultural and language
differences between the German-speaking population of
Switzerland [18]. Secondly, the broad group allocation in
peripheral, central and multifactorial vestibular disorders
was designed to validate the VSS-G for screening people
with vertigo, dizziness or balance disorders prior to vestibu-
lar rehabilitation. Thirdly, the convergent validity analysis
carried out by Tschan and colleagues did not use any
dizziness-specific measurement of disability.
Conclusions
The present German translation of the VSS shows satisfac-
tory psychometric properties for the assessment of the self-
perceived severity of the symptoms on a patient group level
in a large geographic area of German-speaking countries.
The high discriminant validity of the VSS-VER subscale
allows it to be used for screening vestibular dysfunction
and coordinate the treatment. The VSS-AA subscale is able
to screen for symptoms which might refer to an anxiety
disorder, which might be addressed additionally in the con-
text of vestibular rehabilitation.
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